Assessment of the Usefulness of Hemopatch in Coronary Artery Bypass Graft Surgery

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

Also called NCT03340090

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03340090
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Poland (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03340090. Randomized; no masking; primary purpose treatment. Start 2018-03-20 (actual); primary completion 2019-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Assessment of the Usefulness of Hemopatch in Coronary Artery Bypass Graft Surgery
Acronym
Hemopatch
Condition
CHD - Coronary Heart Disease
Intervention (Device)
Medical Device Hemopatch-PEG-coated collagen patch
Lead sponsor
Medical University of Lodz (class: other)
Collaborator
Baxter Healthcare Corporation (class: industry)

Record details

Record id
cardio:ct-nct03340090
Content hash
c27270a0e298b28e5034e589a354e0f7ec876ca4f6bebd55edb7f99e1d920a48